REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Fahrenheit Synthon Pharma (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pt Fahrenheit Synthon Pharma Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Fahrenheit Synthon Pharma is a company in Indonesia, with a head office in Central Jakarta. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on May 18, 2016. From the latest financial highlights, Pt Fahrenheit Synthon Pharma reported a net sales revenue increase of 12.77% in 2024. Its’ total assets recorded a growth of 10.55%.

Headquarters
Kota Jakarta Pusat Kenari Senen Dki Jakarta
Central Jakarta; Jakarta; Postal Code: 10430

Contact Details: Purchase the Pt Fahrenheit Synthon Pharma report to view the information.

Website: http://www.fahrenheit.co.id

Basic Information
Registered Capital:
Purchase the Pt Fahrenheit Synthon Pharma report to view the information.
Financial Auditors:
Purchase the Pt Fahrenheit Synthon Pharma report to view the information.
Incorporation Date:
May 18, 2016
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Fahrenheit Synthon Pharma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
12.77%
Total Operating Revenue
12.77%
Total Assets
10.55%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?